Therapeutic Strategies against Ebola Virus Infection
Since the 2014–2016 epidemic, Ebola virus (EBOV) has spread to several countries and has become a major threat to global health. EBOV is a risk group 4 pathogen, which imposes significant obstacles for the development of countermeasures against the virus. Efforts have been made to develop anti-EBOV...
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
MDPI AG
2022-03-01
|
| Series: | Viruses |
| Subjects: | |
| Acceso en liña: | https://www.mdpi.com/1999-4915/14/3/579 |